Clinical Applications

ElMindA has performed several clinical trials demonstrating breakthrough results in the following areas:

Stroke Treatment: Demonstrated very substantial functional improvement of stroke patients using new treatment procedures; demonstrated ability to accurately predict treatment outcome early in the treatment cycle.
ADHD/ADD: Demonstrated objective diagnosis and potential for treatment ability both with high sensitivity and specificity.
Validation: Validated the technology vis-à-vis fMRI and demonstrated significant value and capabilities over fMRI for daily clinical use; demonstrated brain neural network changes (neural plasticity) before and after treatments in stroke patients in accordance with many fMRI studies.
Pain Management: Demonstrated identification of neural signatures/brain patterns involved in perpetuating pain. Revealed potential for effective pain management and better CNS drug development opportunities.

Key Benefits

ElMindA technology offers key benefits for stroke and ADHD patients:

Neural/Stroke Rehabilitation	Increases overall treatment success rates. Significantly improves patient recovery and functionality parameters. Shortens in-patient period and decreases out-patient and after care costs. Dramatically reduces guess work and generates evidence based treatments. Highly mobile, practical, non-invasive, easy to use and affordable at any point of care.
ADHD Patients	First ever objective bio-marker based diagnosis of a psychiatric disorder. Ability to diagnose large untapped market. Improves overall drugs selection and efficacy. Highly mobile, practical, easy to use and affordable at any point of care.

ElMindA works closely with major medical equipment manufacturers and leading medical centers. For further information, contact us.

For Physicians and Researchers: